Alexander Kulagin Selected Research

Alexander Kulagin Research Topics

7	Graft vs Host Disease (Graft-Versus-Host Disease) 05/2024 - 01/2023
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 11/2022
5	Leukemia 05/2024 - 11/2022
4	Aplastic Anemia (Anemia, Hypoplastic) 04/2024 - 03/2010
4	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 03/2024 - 09/2022
2	Bronchiolitis Obliterans Syndrome 01/2023 - 08/2021
2	idiopathic Aplastic anemia 01/2023 - 01/2022
2	Hodgkin Disease (Hodgkin's Disease) 09/2022 - 11/2021
1	Pathologic Complete Response 05/2024
1	Infections 04/2024
1	WHIM syndrome 04/2024
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Hemolysis 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2023
1	Rare Diseases (Rare Disease) 01/2023
1	COVID-19 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022
1	Fatigue 09/2022
1	Wiskott-Aldrich Syndrome 01/2022
1	Disease Progression 11/2021
1	Pure Red-Cell Aplasia 11/2019
1	Pancytopenia 04/2008
1	Multiple Myeloma 04/2008

9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2024 - 09/2022
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 05/2024 - 01/2024
3	Calcineurin InhibitorsIBA 04/2024 - 01/2023
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 04/2008
2	ravulizumabIBA 03/2024 - 09/2022
2	Complement Inactivating AgentsIBA 01/2023 - 09/2022
1	mavorixaforIBA 04/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2024
1	Methotrexate (Mexate)FDA LinkGeneric 04/2024
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 04/2024
1	AntigensIBA 03/2024
1	SteroidsIBA 01/2023
1	Prostaglandins FIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Biosimilar PharmaceuticalsIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	fludarabineIBA 09/2022
1	Complement C5 (Complement 5)IBA 09/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2022
1	Bendamustine Hydrochloride FDA Link 09/2022
1	eculizumab FDA Link 09/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Alemtuzumab (Campath)FDA Link 03/2010

10	Transplantation 05/2024 - 11/2022
9	Hematopoietic Stem Cell Transplantation 01/2023 - 08/2021
6	Stem Cell Transplantation 05/2024 - 11/2019
3	Haploidentical Transplantation 05/2024 - 11/2022
2	Homologous Transplantation 04/2024 - 01/2023
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022
1	Immunotherapy 11/2021
1	Therapeutics 11/2021
1	Photopheresis 08/2021